Cargando…
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927066/ https://www.ncbi.nlm.nih.gov/pubmed/36730033 http://dx.doi.org/10.15585/mmwr.mm7205e3 |
_version_ | 1784888407590174720 |
---|---|
author | Patel, Pragna Twentyman, Evelyn Koumans, Emily Rosenblum, Hannah Griffin-Blake, Shannon Jackson, Brendan Vagi, Sara |
author_facet | Patel, Pragna Twentyman, Evelyn Koumans, Emily Rosenblum, Hannah Griffin-Blake, Shannon Jackson, Brendan Vagi, Sara |
author_sort | Patel, Pragna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9927066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-99270662023-02-16 Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 Patel, Pragna Twentyman, Evelyn Koumans, Emily Rosenblum, Hannah Griffin-Blake, Shannon Jackson, Brendan Vagi, Sara MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2023-02-03 /pmc/articles/PMC9927066/ /pubmed/36730033 http://dx.doi.org/10.15585/mmwr.mm7205e3 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
spellingShingle | Full Report Patel, Pragna Twentyman, Evelyn Koumans, Emily Rosenblum, Hannah Griffin-Blake, Shannon Jackson, Brendan Vagi, Sara Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title | Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title_full | Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title_fullStr | Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title_full_unstemmed | Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title_short | Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 |
title_sort | information for persons who are immunocompromised regarding prevention and treatment of sars-cov-2 infection in the context of currently circulating omicron sublineages — united states, january 2023 |
topic | Full Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927066/ https://www.ncbi.nlm.nih.gov/pubmed/36730033 http://dx.doi.org/10.15585/mmwr.mm7205e3 |
work_keys_str_mv | AT patelpragna informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT twentymanevelyn informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT koumansemily informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT rosenblumhannah informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT griffinblakeshannon informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT jacksonbrendan informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 AT vagisara informationforpersonswhoareimmunocompromisedregardingpreventionandtreatmentofsarscov2infectioninthecontextofcurrentlycirculatingomicronsublineagesunitedstatesjanuary2023 |